title: Drugs: More shots on target.
authors.forename: Adrianne
authors.initials: A
authors.lastname: Appel
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001896:Boron Compounds / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D005998:Glycine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009842:Oligopeptides / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D015996:Survival Rate; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D013912:Threonine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001896:Boron Compounds; D001897:Boronic Acids; D007155:Immunologic Factors; C554738:ONX 0912; D009842:Oligopeptides; D011480:Protease Inhibitors; D011719:Pyrazines; D013912:Threonine; D013792:Thalidomide; D000069286:Bortezomib; C527966:delanzomib; C548400:ixazomib; C524865:carfilzomib; D000077269:Lenalidomide; D005998:Glycine